Results 161 to 170 of about 21,847 (205)

Btk

2006
openaire   +2 more sources

Next-generation Bruton’s Tyrosine Kinase (BTK) Inhibitors Potentially Targeting BTK C481S Mutation- Recent Developments and Perspectives

Current Topics in Medicinal Chemistry, 2022

exaly  

BTK inhibitors

2015
LIU JIAN, KIM RONALD M, KOZLOWSKI JOSEPH, GUIADEEN DEODIALSINGH, KRIKORIAN ARTO D, YU YOUNONG   +5 more
openaire   +5 more sources

BTK INHIBITORS

2023
MA BIN, HOPKINS BRIAN T, MARX ISAAC, SCHULZ JÜRGEN, VANDEVEER GEORGE, PRINCE ROBIN, NEVALAINEN MARTA, CHEN TEYU, YOUSAF ZAIN, CAPACCI ANDREW GEORGE   +9 more
  +7 more sources

The role of noncovalent BTK inhibitors in the era of covalent BTK inhibitors.

Clinical advances in hematology & oncology : H&O
Despite significantly improving outcomes in patients with B-cell malignancies, covalent Bruton tyrosine kinase (BTK) inhibitors are limited by toxicities and the development of resistance. Some toxicities can be life-threatening, such as cardiotoxicity.
Fateeha, Furqan, Nirav N, Shah
openaire   +1 more source

The Neutrophil Btk Signalosome Regulates Integrin Activation during Sterile Inflammation

Immunity, 2016
Clifford A. Lowell, Alexander Zarbock, Mark Boras   +2 more
exaly  

BTK inhibitors

2014
WU HAO, KIM RONALD M, LIU JIAN, LIU SHILAN, YANG CHUNDAO, ZHENG SHULING   +5 more
openaire   +5 more sources

Development of BTK inhibitors for the treatment of B-cell malignancies

Archives of Pharmacal Research, 2019
Hyung-Ook Kim
exaly  

SSCP at the BTK locus

Human Molecular Genetics, 1994
openaire   +2 more sources

The development of Bruton's tyrosine kinase (BTK) inhibitors from 2012 to 2017: A mini-review

European Journal of Medicinal Chemistry, 2018
Chengyuan Liang, Suresh Thareja, Xiaodong Ren   +2 more
exaly